报价延迟最少15分钟:2026/02/25 21:50 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.13 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.42/-1.40
|
|
企业价值
728.54M
|
| 资产负债 |
|
每股账面净值
0.90
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
2.98M
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology. |
